Compounded medications save lives. They fill critical gaps when commercial drugs are unavailable or ...
The New York Times considered how the official end of the GLP-1 shortages is affecting patients — yo...
“The GLP-1 drug shortage is over. What’s next for the compounders?” asks Pharmaceutical Technology m...
Inside Health Policy covered our letter to FDA protesting the agency's recent (ridiculous) statement...